Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. STAT is hard at work covering the

The new Trump administration could put a stop to pending litigation on the abortion pill mifepristone and other federal abortion policies through changes at the Department of Health and Human Services, according to a top anti-abortion lawyer involved in several pending cases.

Judge Matthew Kacsmaryk, a Trump appointee, allowed three states to go forward with a lawsuit that seeks to change how mifepristone is used.

Trump-appointed judge revives suit to restrict abortion pills access in latest salvo on reproductive rights - The federal judge’s order came less than a week before the 52nd anniversary of Roe

A Texas federal judge Thursday ruled Idaho, Kansas and Missouri can join a case challenging access to the abortion pill.

The federal judge who paved a path for abortion drug clearance to reach the Supreme Court has allowed red states to revive the legal battle against mifepristone. | U.S. District Judge Matthew Kacsmaryk ruled Thursday that Idaho,

Trump granted pardons on his first day in office to hundreds of criminal defendants but left out anti-abortion protesters who were charged with the FACE Act.

The research could further complicate the polarized politics of abortion because the drug in the study is the key ingredient in a pill used for emergency contraception.

Abortion policy could see more changes across the U.S. as President-elect Donald Trump begins his second term and state legislative sessions get rolling

New Jersey already has some of the strongest abortion rights in the United States, but advocates, healthcare providers, and even Gov. Phil Murphy himself are calling for reinforcements ahead of the next presidency.

A double dose of an emergency-contraception pill may open a back door for Americans seeking abortions in restrictive states.